Literature DB >> 32880088

Use of the Jung/Myers Model of Personality Types to Identify and Engage with Individuals at Greatest Risk of Experiencing Depression and Anxiety.

Nathaniel Rickles1, Anthony W Olson2, Paul D Tieger3, Jon C Schommer4, Lawrence M Brown5.   

Abstract

Depression is the leading cause of ill health and disability worldwide. Objectives were (1) to determine the strength of the association between personality type with depression and anxiety using the Preferred Communication Style Questionnaire (PCSQ©) and the Four-Item Patient Health Questionnaire for Depression and Anxiety (PHQ-4) and (2) evaluate the extent to which severity of depression and anxiety is associated with personality type. Data were collected via a self-administered online survey of 10,500. Chi-square analysis compared personality types and depression and anxiety. Practical significance was determined by calculating the percentage-from-expected score based on established statistics reflecting each personality type's percentage in the US population. Personality type was strongly associated with both depression and anxiety with certain types at significantly greater risk than others. Findings can improve the research and clinical community's understanding of the specific risk factors and triggers for depression and anxiety, and result in more efficacious, tailored treatment options.
© 2020. National Council for Behavioral Health.

Entities:  

Year:  2021        PMID: 32880088     DOI: 10.1007/s11414-020-09724-2

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN: 1094-3412            Impact factor:   1.505


  1 in total

1.  An ultra-brief screening scale for anxiety and depression: the PHQ-4.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Bernd Löwe
Journal:  Psychosomatics       Date:  2009 Nov-Dec       Impact factor: 2.386

  1 in total
  1 in total

1.  Stronger Together! Meeting the Challenges of a Year Defined by a Pandemic.

Authors:  Chuck Ingoglia
Journal:  J Behav Health Serv Res       Date:  2021-07       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.